Cargando…
Development of primary human pancreatic cancer organoids, matched stromal and immune cells and 3D tumor microenvironment models
BACKGROUND: Patient-derived tumor models are the new standard for pre-clinical drug testing and biomarker discovery. However, the emerging technology of primary pancreatic cancer organoids has not yet been broadly implemented in research, and complex organotypic models using organoids in co-culture...
Autores principales: | Tsai, Susan, McOlash, Laura, Palen, Katie, Johnson, Bryon, Duris, Christine, Yang, Qiuhui, Dwinell, Michael B., Hunt, Bryan, Evans, Douglas B., Gershan, Jill, James, Michael A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5870823/ https://www.ncbi.nlm.nih.gov/pubmed/29587663 http://dx.doi.org/10.1186/s12885-018-4238-4 |
Ejemplares similares
-
Changes in immune checkpoint protein expression on CD8 T cells during neoadjuvant therapy in patients with pancreatic cancer
por: Tsai, Susan, et al.
Publicado: (2014) -
Adoptive cell therapy using PD-1(+) myeloma-reactive T cells eliminates established myeloma in mice
por: Jing, Weiqing, et al.
Publicado: (2017) -
STING agonist inflames the pancreatic cancer immune microenvironment and reduces tumor burden in mouse models
por: Jing, Weiqing, et al.
Publicado: (2019) -
E-cadherin re-expression shows in vivo evidence for mesenchymal to epithelial transition in clonal metastatic breast tumor cells
por: Palen, Katie, et al.
Publicado: (2016) -
Combined immune checkpoint protein blockade and low dose whole body irradiation as immunotherapy for myeloma
por: Jing, Weiqing, et al.
Publicado: (2015)